accountmade.
GTM Research
Read the report
GTM Research · Report

Sales has become the default motion earlier than the playbook admits.

We scored 201 companies on ten go-to-market motions across six funding stages and twelve categories, then read what actually changes round by round — and what the averages hide.

By the Accountmade team July 2026 5 min overview Corpus of 201 companies

Most go-to-market advice ranks the biggest companies and reasons backward — a leaderboard that is ~80% late-stage and public, converged on the same hybrid. We did the opposite: we designed a sample to fill a matrix, weighted toward the Seed-to-Series-B founders and first reps who actually feel the stage-mismatch. Every number below traces to the corpus; nothing is borrowed from an external benchmark. This page is the overview — the full argument, with every figure, is in the report.

An Accountmade corpus study
Sales has become the default motion earlier than the playbook admits.
201 companies · 15 chapters · 8 figures · July 2026

The State of Go-To-Market 2026

The full report — 15 chapters, 8 figures, a corpus of 201 companies. Read on the web or download the print PDF.
Finding 01 · The record

Sales is the default — and it arrives early

Across 201 companies scored on ten motions, sales-led is the weighted top motion in five of six stage bands — including Seed. The tidy "start product-led, bolt on sales at Series B" sequence isn't the general rule: by the time a company leaves enough public evidence to study, it is already carrying a sales motion. What changes round by round isn't whether sales is present, but how legible the stack becomes.

Figure 1Weighted motion centroid · N=201
The motion stack tightens toward sales, round by round
Sales-led leads at every stage and rises into the public band; product-led-sales holds second; pure product-led stays a minority throughout.
Finding 02 · What works

Series B is the proving ground — but motion doesn't predict the outcome

Win-rate jumps from 27% at Series A to 60% at Series B and peaks at 75% in Growth, then derates at Public. Yet the corpus's most useful result is a null: compare the average motion of the winners with the stalled companies and they are, to the decimal, the same posture. "Which motion should we run" is the wrong question — the winners and the failures ran the same ones.

Figure 2Outcome mix by stage · N=201
Series B is where the motion proves out; public is where it derates
Win-rate (above each bar) climbs to Series B and Growth, then falls at Public, where 65% of the observed cohort is stalled or down from peak.
Failure in the corpus rarely looks like the wrong motion. It looks like the right motion, mistimed for the buyer in the room.
Finding 03 · The sectors

"Software company" hides twelve different machines

The corpus-wide average is a useful lie. Split by category and each sector runs a recognisably different motion — dictated by who signs. Security sells to InfoSec, so trust leads from the first deal; developer tools sell to a developer, the one sector where sales-led isn't even the top motion. Same "software," opposite machines, for the same reason: the buyer.

Figure 3Weighted motion mix per category
From most sales-led to most product-led
Every sector's motion mix on one axis, ordered most sales-led to most product-led. The sales band shrinks down the list; the trust band appears only where the buyer is a security reviewer.
Methodology

How we mapped it

The analytical unit is a (stage × category) cell, not a ranked list. Companies were selected to populate those cells — weighted toward the ICP, not chosen for size — then each was stamped on four axes: stage, category, ACV band × buyer, and an outcome signal. Motion itself is a ten-way vector summing to ~1 over company-neutral archetypes.

Two rules do the load-bearing work. Anti-survivorship: 15–20% of every stage band is a stalled or down-round company — without a failure cohort you can only learn what winners did. Traceability: every claim carries a dated public source or is flagged as an inference, and a second adversarial pass tried to refute the record. No external benchmark contributed a single number.

201companies, structured and scored
67stage × category cells mapped
27stalled / down-round, sourced on purpose
129units passed adversarial verification
The synthesis

Six laws of modern go-to-market

The patterns that recur across the corpus — the part a founder can carry into a room.

Law 1

Motion is a buyer property, not a stage.

Stage barely moves the motion; the buyer moves it. When a developer is in the buying group, sales-led falls to 0.17 against 0.25 for everyone else — the largest swing in the corpus.

Law 2

The security questionnaire is the channel.

Direct sales, partners, and a distinct procurement/trust channel are the three most load-bearing ways companies reach buyers. The dominant channel in modern B2B is not a signup page — it is a security review, answered well.

Law 3

Trust beats hype — but only at the margin.

Motion does not predict outcome: winners and stalled companies run the same mix. The only tilt that survives is small — winners carry slightly more procurement/trust weight (0.12 vs 0.10).

Law 4

Growth left the seat.

Expansion splits across usage, new modules, and seats — usage just ahead — and usage-based billing now rivals the per-seat subscription. Revenue increasingly grows with usage, not headcount.

Law 5

Nobody runs one motion; the blend is the strategy.

The average company's strongest motion carries just a quarter of its weight (0.26); 152 of 201 are pure hybrids and only 7 are monoline. The winning object is a stack, tuned.

Law 6

When companies change, they change the product — lately, into AI.

Of 179 documented shifts in the last year, 61% shipped a new product and 42% repositioned around AI; only 16% changed how they sell. The motion of the year didn't change — the product did.

The full analysis

Fifteen chapters, eight figures, one corpus.

The complete report goes deep on the exception map, the channel stack, the two-buyer proof, motion decomposition, and three specimens that break their cell — every figure traceable to source.